Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Sulphonamides market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Sulphonamides market. Detailed analysis of key players, along with key growth strategies adopted by Sulphonamides industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Stiefel Laboratories
Sanofi Aventis
GlaxoSmithKline
Bayer AG
King Pharmaceuticals
Par Pharmaceutical
Boehringer Ingelheim Pharmaceuticals
Novartis International AG
Pfizer
Mylan Pharmaceuticals
Abbott Laboratories
Roche Holding AG
By Type:
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
By End-User:
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Sulphonamides Market
-
1.3 Market Segment by Type
1.3.1 Japan Sulphonamides Market Size and Growth Rate of Orally Absorbable Sulfonamide from 2014 to 2026
1.3.2 Japan Sulphonamides Market Size and Growth Rate of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) from 2014 to 2026
1.3.3 Japan Sulphonamides Market Size and Growth Rate of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Sulphonamides Market Size and Growth Rate of Skin Infections from 2014 to 2026
1.4.2 Japan Sulphonamides Market Size and Growth Rate of Gastro Intestinal Tract (GIT) Infection from 2014 to 2026
1.4.3 Japan Sulphonamides Market Size and Growth Rate of Meningitis from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Sulphonamides Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Sulphonamides by Major Types
3.4.1 Market Size and Growth Rate of Orally Absorbable Sulfonamide
3.4.2 Market Size and Growth Rate of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
3.4.3 Market Size and Growth Rate of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
4 Segmentation of Sulphonamides Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Sulphonamides by Major End-Users
4.4.1 Market Size and Growth Rate of Sulphonamides in Skin Infections
4.4.2 Market Size and Growth Rate of Sulphonamides in Gastro Intestinal Tract (GIT) Infection
4.4.3 Market Size and Growth Rate of Sulphonamides in Meningitis
5 Market Analysis by Regions
-
5.1 Japan Sulphonamides Production Analysis by Regions
-
5.2 Japan Sulphonamides Consumption Analysis by Regions
6 Hokkaido Sulphonamides Landscape Analysis
-
6.1 Hokkaido Sulphonamides Landscape Analysis by Major Types
-
6.2 Hokkaido Sulphonamides Landscape Analysis by Major End-Users
7 Tohoku Sulphonamides Landscape Analysis
-
7.1 Tohoku Sulphonamides Landscape Analysis by Major Types
-
7.2 Tohoku Sulphonamides Landscape Analysis by Major End-Users
8 Kanto Sulphonamides Landscape Analysis
-
8.1 Kanto Sulphonamides Landscape Analysis by Major Types
-
8.2 Kanto Sulphonamides Landscape Analysis by Major End-Users
9 Chubu Sulphonamides Landscape Analysis
-
9.1 Chubu Sulphonamides Landscape Analysis by Major Types
-
9.2 Chubu Sulphonamides Landscape Analysis by Major End-Users
10 Kinki Sulphonamides Landscape Analysis
-
10.1 Kinki Sulphonamides Landscape Analysis by Major Types
-
10.2 Kinki Sulphonamides Landscape Analysis by Major End-Users
11 Chugoku Sulphonamides Landscape Analysis
-
11.1 Chugoku Sulphonamides Landscape Analysis by Major Types
-
11.2 Chugoku Sulphonamides Landscape Analysis by Major End-Users
12 Shikoku Sulphonamides Landscape Analysis
-
12.1 Shikoku Sulphonamides Landscape Analysis by Major Types
-
12.2 Shikoku Sulphonamides Landscape Analysis by Major End-Users
13 Kyushu Sulphonamides Landscape Analysis
-
13.1 Kyushu Sulphonamides Landscape Analysis by Major Types
-
13.2 Kyushu Sulphonamides Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Stiefel Laboratories
14.1.1 Stiefel Laboratories Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Sanofi Aventis
14.2.1 Sanofi Aventis Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 GlaxoSmithKline
14.3.1 GlaxoSmithKline Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Bayer AG
14.4.1 Bayer AG Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 King Pharmaceuticals
14.5.1 King Pharmaceuticals Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Par Pharmaceutical
14.6.1 Par Pharmaceutical Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Boehringer Ingelheim Pharmaceuticals
14.7.1 Boehringer Ingelheim Pharmaceuticals Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Novartis International AG
14.8.1 Novartis International AG Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Pfizer
14.9.1 Pfizer Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Mylan Pharmaceuticals
14.10.1 Mylan Pharmaceuticals Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Abbott Laboratories
14.11.1 Abbott Laboratories Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 Roche Holding AG
14.12.1 Roche Holding AG Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
The List of Tables and Figures (Totals 106 Figures and 124 Tables)
Figure Japan Sulphonamides Market Size and Growth Rate of Orally Absorbable Sulfonamide from 2014 to 2026
Figure Japan Sulphonamides Market Size and Growth Rate of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) from 2014 to 2026
Figure Japan Sulphonamides Market Size and Growth Rate of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Sulphonamides Market Size and Growth Rate of Skin Infections from 2014 to 2026
Figure Japan Sulphonamides Market Size and Growth Rate of Gastro Intestinal Tract (GIT) Infection from 2014 to 2026
Figure Japan Sulphonamides Market Size and Growth Rate of Meningitis from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Sulphonamides Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Sulphonamides Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Sulphonamides
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Sulphonamides by Different Types from 2014 to 2026
-
Table Consumption Share of Sulphonamides by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Orally Absorbable Sulfonamide
Figure Market Size and Growth Rate of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Figure Market Size and Growth Rate of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Sulphonamides by Different End-Users from 2014 to 2026
-
Table Consumption Share of Sulphonamides by Different End-Users from 2014 to 2026
Figure Japan Sulphonamides Market Size and Growth Rate of Skin Infections from 2014 to 2026
Figure Japan Sulphonamides Market Size and Growth Rate of Gastro Intestinal Tract (GIT) Infection from 2014 to 2026
Figure Japan Sulphonamides Market Size and Growth Rate of Meningitis from 2014 to 2026
-
Table Japan Sulphonamides Production by Regions
-
Table Japan Sulphonamides Production Share by Regions
-
Figure Japan Sulphonamides Production Share by Regions in 2014
-
Figure Japan Sulphonamides Production Share by Regions in 2018
-
Figure Japan Sulphonamides Production Share by Regions in 2026
-
Table Japan Sulphonamides Consumption by Regions
-
Table Japan Sulphonamides Consumption Share by Regions
-
Figure Japan Sulphonamides Consumption Share by Regions in 2014
-
Figure Japan Sulphonamides Consumption Share by Regions in 2018
-
Figure Japan Sulphonamides Consumption Share by Regions in 2026
-
Table Hokkaido Sulphonamides Consumption by Types from 2014 to 2026
-
Table Hokkaido Sulphonamides Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Sulphonamides Consumption Share by Types in 2014
-
Figure Hokkaido Sulphonamides Consumption Share by Types in 2018
-
Figure Hokkaido Sulphonamides Consumption Share by Types in 2026
-
Table Hokkaido Sulphonamides Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Sulphonamides Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Sulphonamides Consumption Share by End-Users in 2014
-
Figure Hokkaido Sulphonamides Consumption Share by End-Users in 2018
-
Figure Hokkaido Sulphonamides Consumption Share by End-Users in 2026
-
Table Tohoku Sulphonamides Consumption by Types from 2014 to 2026
-
Table Tohoku Sulphonamides Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Sulphonamides Consumption Share by Types in 2014
-
Figure Tohoku Sulphonamides Consumption Share by Types in 2018
-
Figure Tohoku Sulphonamides Consumption Share by Types in 2026
-
Table Tohoku Sulphonamides Consumption by End-Users from 2014 to 2026
-
Table Tohoku Sulphonamides Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Sulphonamides Consumption Share by End-Users in 2014
-
Figure Tohoku Sulphonamides Consumption Share by End-Users in 2018
-
Figure Tohoku Sulphonamides Consumption Share by End-Users in 2026
-
Table Kanto Sulphonamides Consumption by Types from 2014 to 2026
-
Table Kanto Sulphonamides Consumption Share by Types from 2014 to 2026
-
Figure Kanto Sulphonamides Consumption Share by Types in 2014
-
Figure Kanto Sulphonamides Consumption Share by Types in 2018
-
Figure Kanto Sulphonamides Consumption Share by Types in 2026
-
Table Kanto Sulphonamides Consumption by End-Users from 2014 to 2026
-
Table Kanto Sulphonamides Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Sulphonamides Consumption Share by End-Users in 2014
-
Figure Kanto Sulphonamides Consumption Share by End-Users in 2018
-
Figure Kanto Sulphonamides Consumption Share by End-Users in 2026
-
Table Chubu Sulphonamides Consumption by Types from 2014 to 2026
-
Table Chubu Sulphonamides Consumption Share by Types from 2014 to 2026
-
Figure Chubu Sulphonamides Consumption Share by Types in 2014
-
Figure Chubu Sulphonamides Consumption Share by Types in 2018
-
Figure Chubu Sulphonamides Consumption Share by Types in 2026
-
Table Chubu Sulphonamides Consumption by End-Users from 2014 to 2026
-
Table Chubu Sulphonamides Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Sulphonamides Consumption Share by End-Users in 2014
-
Figure Chubu Sulphonamides Consumption Share by End-Users in 2018
-
Figure Chubu Sulphonamides Consumption Share by End-Users in 2026
-
Table Kinki Sulphonamides Consumption by Types from 2014 to 2026
-
Table Kinki Sulphonamides Consumption Share by Types from 2014 to 2026
-
Figure Kinki Sulphonamides Consumption Share by Types in 2014
-
Figure Kinki Sulphonamides Consumption Share by Types in 2018
-
Figure Kinki Sulphonamides Consumption Share by Types in 2026
-
Table Kinki Sulphonamides Consumption by End-Users from 2014 to 2026
-
Table Kinki Sulphonamides Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Sulphonamides Consumption Share by End-Users in 2014
-
Figure Kinki Sulphonamides Consumption Share by End-Users in 2018
-
Figure Kinki Sulphonamides Consumption Share by End-Users in 2026
-
Table Chugoku Sulphonamides Consumption by Types from 2014 to 2026
-
Table Chugoku Sulphonamides Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Sulphonamides Consumption Share by Types in 2014
-
Figure Chugoku Sulphonamides Consumption Share by Types in 2018
-
Figure Chugoku Sulphonamides Consumption Share by Types in 2026
-
Table Chugoku Sulphonamides Consumption by End-Users from 2014 to 2026
-
Table Chugoku Sulphonamides Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Sulphonamides Consumption Share by End-Users in 2014
-
Figure Chugoku Sulphonamides Consumption Share by End-Users in 2018
-
Figure Chugoku Sulphonamides Consumption Share by End-Users in 2026
-
Table Shikoku Sulphonamides Consumption by Types from 2014 to 2026
-
Table Shikoku Sulphonamides Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Sulphonamides Consumption Share by Types in 2014
-
Figure Shikoku Sulphonamides Consumption Share by Types in 2018
-
Figure Shikoku Sulphonamides Consumption Share by Types in 2026
-
Table Shikoku Sulphonamides Consumption by End-Users from 2014 to 2026
-
Table Shikoku Sulphonamides Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Sulphonamides Consumption Share by End-Users in 2014
-
Figure Shikoku Sulphonamides Consumption Share by End-Users in 2018
-
Figure Shikoku Sulphonamides Consumption Share by End-Users in 2026
-
Table Kyushu Sulphonamides Consumption by Types from 2014 to 2026
-
Table Kyushu Sulphonamides Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Sulphonamides Consumption Share by Types in 2014
-
Figure Kyushu Sulphonamides Consumption Share by Types in 2018
-
Figure Kyushu Sulphonamides Consumption Share by Types in 2026
-
Table Kyushu Sulphonamides Consumption by End-Users from 2014 to 2026
-
Table Kyushu Sulphonamides Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Sulphonamides Consumption Share by End-Users in 2014
-
Figure Kyushu Sulphonamides Consumption Share by End-Users in 2018
-
Figure Kyushu Sulphonamides Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Stiefel Laboratories
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stiefel Laboratories
Figure Sales and Growth Rate Analysis of Stiefel Laboratories
Figure Revenue and Market Share Analysis of Stiefel Laboratories
Table Product and Service Introduction of Stiefel Laboratories
Table Company Profile and Development Status of Sanofi Aventis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Aventis
Figure Sales and Growth Rate Analysis of Sanofi Aventis
Figure Revenue and Market Share Analysis of Sanofi Aventis
Table Product and Service Introduction of Sanofi Aventis
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of Bayer AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
Figure Sales and Growth Rate Analysis of Bayer AG
Figure Revenue and Market Share Analysis of Bayer AG
Table Product and Service Introduction of Bayer AG
Table Company Profile and Development Status of King Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of King Pharmaceuticals
Figure Sales and Growth Rate Analysis of King Pharmaceuticals
Figure Revenue and Market Share Analysis of King Pharmaceuticals
Table Product and Service Introduction of King Pharmaceuticals
Table Company Profile and Development Status of Par Pharmaceutical
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Par Pharmaceutical
Figure Sales and Growth Rate Analysis of Par Pharmaceutical
Figure Revenue and Market Share Analysis of Par Pharmaceutical
Table Product and Service Introduction of Par Pharmaceutical
Table Company Profile and Development Status of Boehringer Ingelheim Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim Pharmaceuticals
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim Pharmaceuticals
Figure Revenue and Market Share Analysis of Boehringer Ingelheim Pharmaceuticals
Table Product and Service Introduction of Boehringer Ingelheim Pharmaceuticals
Table Company Profile and Development Status of Novartis International AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International AG
Figure Sales and Growth Rate Analysis of Novartis International AG
Figure Revenue and Market Share Analysis of Novartis International AG
Table Product and Service Introduction of Novartis International AG
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Mylan Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharmaceuticals
Figure Sales and Growth Rate Analysis of Mylan Pharmaceuticals
Figure Revenue and Market Share Analysis of Mylan Pharmaceuticals
Table Product and Service Introduction of Mylan Pharmaceuticals
Table Company Profile and Development Status of Abbott Laboratories
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
Figure Sales and Growth Rate Analysis of Abbott Laboratories
Figure Revenue and Market Share Analysis of Abbott Laboratories
Table Product and Service Introduction of Abbott Laboratories
Table Company Profile and Development Status of Roche Holding AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Holding AG
Figure Sales and Growth Rate Analysis of Roche Holding AG
Figure Revenue and Market Share Analysis of Roche Holding AG
Table Product and Service Introduction of Roche Holding AG
-
